New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
07:43 EDTAGIOAgios Pharmaceuticals price target raised to $51 from $38 at Leerink
Leerink raised its price target for Agios Pharmaceuticals shares to $51 saying the Phase I data presentation for the AG-221 in IDH2 mutant hematologic malignancies is coming much sooner than expected. The firm keeps an Outperform rating on the stock.
News For AGIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
15:06 EDTAGIOAgios Pharmaceuticals announces orphan drug designation of AG-348
Subscribe for More Information
14:03 EDTAGIOAgios pyruvate kinase deficiency treatment granted FDA orphan status
The FDA designated an allosteric activator of the red blood cell-specific form of pyruvate kinase from Agios Pharmaceuticals as an orphan treatment of pyruvate kinase deficiency, the FDA stated in a post to its site. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use